Guaifenesin Tablet
Product Images NDC 11673-840

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 11673-840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Target Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

14ct (14ct Ggf 1200mg)

Label for Guaifenesin 1200 mg extended-release bi-layer tablets from up&up, a Target Corporation brand. The product is branded as Mucus Relief, with 14 tablets per package. The label highlights its use to relieve chest congestion by thinning and loosening mucus, offering immediate and extended release over 12 hours. It includes drug facts, active and inactive ingredients, usage directions, and safety warnings.*

FDA Label Image

28ct (28ct Ggf 1200mg)

Packaging label for up&up Maximum Strength Mucus Relief Guaifenesin Extended-Release Tablets 1,200 mg. The label shows 28 extended-release bi-layer tablets, indicating expectorant use. It includes the up&up logo, directions, warnings, inactive ingredients, and barcode. Distributed by Target Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.